Lisocabtagene Maraleucel (liso-cel) in R/R CLL/SLL: 24-Month Median Follow-up of TRANSCEND CLL 004

Siddiqi, T; Maloney, DG; Kenderian, SS; Brander, DM; Dorritie, K; Soumerai, J; Riedell, PA; Shah, NN; Nath, R; Fakhri, B; Stephens, DM; Ma, S; Feldman, T; Solomon, SR; Schuster, SJ; Perna, SK; Tuazon, SA; Ou, SS; Rane, N; Wierda, WG

BLOOD, 2023; 142 ():